Daily hemodialysis improves survival in acute renal failure in the ICU.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Boban Thomas.
Explore the source record for details and available documents.
OBJECTIVES: To develop a protocol to risk stratify patients before ICD implantation in ischemic left ventricular dysfunction using magnetic resonance imaging and a gadolinium-based contrast agent. Ejection fraction as determined by other methods was reconfirmed using cardiac MRI. METHODS: Five patients considered for implantation of an ICD were prospectively offered a cardiac MR exam between Novem-ber 2003 and June 2004. All had a history of MI and LV dysfunction, had undergone complete coronary revascularization or were considered ineligible for revascularization. RESULTS: In three patients the MR ejection fractions were less than 30%, confirming the values detected by echocardiography. One patient had a larger EF by MRI compared to echo and ICD implantation was deferred. One patient thought to have an EF greater than 35% by echo on three studies was confirmed to have a much lower EF by MRI and was selected to undergo ICD implantation. CONCLUSION: Cardiac MRI can be used to further stratify patients selected for an ICD. Ejection fraction can be more reliably estimated by MRI and the presence of extensive scar can be detected. The presence of extensive scar and a low ejection fraction, which are two factors known to predispose patients to sudden cardiac death in ischemic left ventricular dysfunction, can be studied reliably by MRI.
OBJECTIVE: To compare direct planimetry of aortic valve area (AVA) by cardiac magnetic resonance (CMR) imaging with transthoracic echocardiography (TTE), using the continuity equation. METHODS: 15 symptomatic patients with aortic stenosis were studied. AVA was measured with CMR from steady state free precession imaging by planimetry. AVA was also calculated by TTE images using the continuity equation. RESULTS: The evaluation of AVA by both CMR and TTE was possible in twelve out of fifteen patients. CMR was able to determine the AVA in all fifteen patients. AVAs obtained by CMR and TTE were very similar and a good correlation existed between the values obtained by either technique. CONCLUSION: CMR planimetry is highly reliable and reproducible. AVAs obtained by CMR compare well with those obtained by TTE. Therefore, CMR planimetry of AVA with steady state free precession is a useful diagnostic tool, particularly if uncertainty exists.
The presence of a pacemaker or an implantable cardioverter-defibrillator was considered an absolute contraindication for a magnetic resonance imaging study until recently. The publication of numerous studies, albeit with small numbers of patients, has challenged this assumption. With no serious adverse effects detected, it is evident that more patients with these devices will undergo an MR study. While we feel that no patient with an implanted device should be denied a potentially beneficial exam, some caution is obviously prudent and planning the study will enhance the benefit that the patient will derive while minimizing the risks.
Explore the source record for details and available documents.
We report a case of an asymptomatic adult patient, with several congenital malformations including an infrequent variant of double orifice mitral valve, postductal aortic coarctation, bicuspid aortic valve and an aneurysm of the right Valsalva sinus. The loss of support of the right coronary cusp of the aortic valve caused major aortic regurgitation. With the exception of the mitral valve, which was left untouched because it was neither stenotic nor regurgitant, all the other abnormalities were successfully corrected, in a two-step surgical approach.
OBJECTIVE: Based on the PAMI 1 and 2, AIR PAMI, and STENT PAMI trials, a risk score to predict mortality in patients undergoing primary angioplasty was recently proposed--the PAMI risk score. It includes only 6 parameters. As one of the first tools available to predict mortality in this group of patients, it results from controlled trials, with restricted inclusion criteria. It was our objective to evaluate how the PAMI risk score applies to "real world" patients. METHODS: 149 patients (mean age 58.2 +/- 13.6 years, 113 male) undergoing primary angioplasty were included. The PAMI risk score was applied and the patients were divided in 3 groups: 0 to 2 points (group A), 3 to 6 points (group B) and > or =7 points (group C). RESULTS: Sixty-eight patients (46%) were included in group A, 41 (27%) in group B and 40 (27%) in group C. There were no significant differences in pain-to-balloon times between the 3 groups. Immediate mortality (0%, 2.4% and 15%: p = 0.001), in-hospital mortality (2.9%, 7.3% and 37.5%; p < 0.001), 30-day mortality (2.9%, 7.3% and 37.5%; p < 0.001) and 6-month mortality (4.4%, 14.6% and 45%; p < 0.001) were significantly different between the 3 groups. CONCLUSIONS: The PAMI risk score is a simple prognostic tool, with parameters that can be easily acquired, enabling reliable prediction of immediate, in-hospital, 30-day and 6-month mortality in patients with acute myocardial infarction treated with primary angioplasty.
OBJECTIVES: To evaluate myocardial infarcts using a segmented inversion-recovery prepared gradient echo sequence on a 1.5 Tesla MR scanner after injection of a gadolinium-based contrast agent. METHODS: Fourteen patients were prospectively offered a cardiac MR exam between November 2003 and February 2004. Six patients had a history of anterior wall MI, six had a history of inferior wall MI and two patients had MI of undetermined location. RESULTS: Delayed enhancement indicating the presence of scarring was visualized in all fourteen patients. The scarring was transmural in ten patients and non-transmural in four patients. CONCLUSION: Delayed enhancement of infarcted areas in the myocardium after injection of gadolinium-based contrast agent represents scarring and adequate resolution exists to distinguish transmural from non-transmural scarring. This technique is useful in determining viability of infarcted myocardium, may detect infarcts missed by SPECT and may help in the selection of patients for implantation of defibrillators.
OBJECTIVES: A protocol to evaluate myocardial viability in ischemic left ventricular dysfunction using magnetic resonance imaging and a gadolinium-based contrast agent. METHODS: Twenty-two patients were prospectively offered a cardiac MR exam between November 2003 and June 2004. Twelve had a history of anterior wall MI, eight had a history of inferior wall MI and two patients had MI of undetermined location. Eight patients had left ventricular dysfunction. RESULTS: No patient with transmural scarring extending through more than 75% of the wall recovered normal wall motion despite revascularization when evaluated fourteen months later. Of the other three with scarring extending to less than 75% there was recovery in two patients. CONCLUSION: Viability assessment by cardiac MR using gadolinium contrast is a robust technique. No segment with >75% transmural enhancement (TE) recovers despite revascularization, while all segments with <25% TE recover contractility. Between these two extremes, methods other than extent of TE may have to be used, particularly low-dose dobutamine stress testing or evaluation of percentage of hyperenhanced area compared to the normal area in each segment.
OBJECTIVES: To assess the feasibility of performing pulmonary angiography using MRI with contrast enhancement in patients with pulmonary vascular disease. METHODS: We present our experience in ten individuals, two controls and eight patients who underwent the exam after injection of a gadolinium-based contrast agent on a 1 Tesla MR scanner using a time-of-flight sequence and breath-holding during injection of contrast. RESULTS: Pathology in the main pulmonary artery and its major branches was detected easily while resolution at the segmental and subsegmental levels was inadequate. CONCLUSION: Contrast-enhanced magnetic resonance pulmonary angiography is feasible on a 1 Tesla MR scanner for the study of pathology of the main pulmonary artery and its major branches, like massive pulmonary embolism. However its ability to detect and define distal vessel pathology as found in chronic thromboembolic pulmonary hypertension and small pulmonary emboli is limited.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Chronic total occlusions present technical challenges to the interventional cardiologist, and are accompanied by an increased propensity for complications. We present an argument for the routine use of simultaneous bilateral coronary angiography to help define the lesion and optimize the therapeutic approach. Eight selected cases of CTO were revascularized using this technique resulting in immediate procedural success, devoid of complications, in all cases.
METHODS: To assess the safety and feasibility of transfer of patients requiring urgent cardiac surgery, from a hospital without onsite cardiac surgical facilities, after insertion of an intra-aortic balloon pump (IABP) to maintain clinical and hemodynamic stability, a retrospective review of all cardiac charactheterizations was performed. Sixty-two patients required IABPs, among whom 24 were transported to a surgical center from the outskirts of Lisbon to the city center in an ambulance accompanied by a physician, a nurse and paramedical personnel. RESULTS: Patients who required hemodynamic support with IABPs usually had unstable angina with critical coronary lesions requiring immediate surgical intervention, hypotensive patients with mechanical complications after an AMI, and patients with AMI who did not receive thrombolytic therapy, and with coronary lesions not amenable to percutaneous coronary intervention. All patients reached the surgical center alive, and no patient had either hemodynamic or electrical instability during transport. CONCLUSIONS: Surface transport of patients requiring emergency cardiac surgery after insertion of IABPs is safe, feasible and may provide circulatory and clinical stability in a subset of critically-ill patients.
OBJECTIVES: To assess the feasibility of performing high resolution reconstructed three-dimensional aortic angiography on a 1 Tesla magnetic resonance imaging scanner in patients with aortic diseases. METHODS: Seventeen patients underwent thirty-one MR exams that included fast spin echo, gradient echo and time-of-flight angiography acquisitions after administration of a commercially available gadolinium contrast agent injected as a bolus. RESULTS: All scans were well tolerated and aortic lumen opacification was achieved at the appropriate time in all patients. The angiography scans were obtained with breath-held sequences that required approximately 25 seconds to scan and six to eight minutes to form a three-dimensional reconstruction. CONCLUSION: Three-dimensional aortic angiography is feasible on a 1 Tesla scanner, with images of extremely high quality and resolution, achieved in a few minutes. It is possible to acquire all the information that conventional or fast spin echo provides from the reconstructed three-dimensional scans, avoiding the need for the cumbersome acquisition of the spin echo images, improving speed and decreasing imaging times, which may be of importance in patients with acute aortic syndromes.